Search results for " dose"

showing 10 items of 593 documents

A Multicenter Trial of Specific Local Nasal Immunotherapy

2000

Objective: To assess the efficacy and safety of specific local nasal immunotherapy (LNIT) in powder form in patients with allergic rhinitis, using subjective and objective parameters. Study Design: A double-blind randomized multicenter trial of 102 patients with allergic rhinitis who were treated with specific LNIT for 8 consecutive months. Methods: After identifying allergens with the skin prick test and sensitization threshold dose with the specific nasal provocation test, 102 patients were selected, of whom 55 were allergic to mites and 47 were allergic to Graminaceae or Parietaria pollen. The specific treatments were self-administered using an insufflator in two phases (phase 1: increas…

Allergymedicine.medical_specialtyParietariabiologymedicine.diagnostic_testMaintenance dosebusiness.industryMucociliary clearancemedicine.medical_treatmentbiology.organism_classificationmedicine.diseaseDermatologyNasal provocation testOtorhinolaryngologyMulticenter trialImmunologymedicineRhinomanometrybusinessDesensitization (medicine)The Laryngoscope
researchProduct

The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

2014

This guideline is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It is a joint initiative of the Dermatology Section of the European Academy of Allergy and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA(2)LEN), the European Dermatology Forum (EDF), and the World Allergy Organization (WAO) with the participation of delegates of 21 national and international societies. Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioe…

Allergymedicine.medical_specialtyhivesImmunologylcsh:Medicine610 Medicine & healthDermatologyDiseaseurticariaimmune system diseaseslcsh:DermatologyHumansImmunology and AllergyMedicinemedia_common.cataloged_instanceEuropean unionskin and connective tissue diseaseswhealAsthmamedia_common2403 ImmunologyAcute urticariaAngioedemabusiness.industryangioedemalcsh:RConsensus conferenceangioedema; consensus; hives; urticaria; wheal; Humans; Urticaria10177 Dermatology ClinicGuidelinelcsh:RL1-803angioedema consensus hives urticaria wheal CHRONIC IDIOPATHIC URTICARIA QUALITY-OF-LIFE SERUM SKIN-TEST DELAYED PRESSURE URTICARIA DOSE INTRAVENOUS IMMUNOGLOBULIN ANTIIMMUNOGLOBULIN-E THERAPY RESISTANT CHRONIC URTICARIA RANDOMIZED CONTROLLED-TRIAL ULTRAVIOLET-B PHOTOTHERAPY WORLD-HEALTH-ORGANIZATIONmedicine.diseaseDermatologySystematic reviewconsensusFamily medicine2723 Immunology and Allergymedicine.symptombusinessAllergy
researchProduct

Qip-Mass Spectrometry in High Risk Smoldering Multiple Myeloma Patients Included in the GEM-CESAR Trial: Comparison with Conventional and Minimal Res…

2019

Introduction: The GEM-CESAR trial is a potentially curative strategy for high-risk smoldering multiple myeloma (HRsMM) patients in which the primary endpoint is the assessment of bone marrow minimal residual disease negativity by next generation flow (NGF). However, alternative methods of tumor burden evaluation in serum, like Quantitative Immunoprecipitation Mass Spectrometry (QIP-MS), a polyclonal antibody-based technology to identify intact immunoglobulins, have been also evaluated. Patients and Methods: Ninety HRsMM patients included in the GEM-CESAR trial received six 4-weeks cycles of carfilzomib, lenalidomide and dexamethasone followed by high dose melphalan and ASCT and 2 further cy…

Alternative methodsmedicine.medical_specialtybusiness.industryImmunologyTumor burdenHigh dose melphalanCell BiologyHematologymedicine.diseaseBiochemistryMinimal residual diseaseTransplantationResponse assessmentFamily medicineMedicineIn patientbusinessMultiple myelomaBlood
researchProduct

Are we overusing abdominal computed tomography scans in young patients referred in an emergency for acute abdominal pain?

2022

Purpose: The primary objective was to assess the frequency of appropriateness of computed tomography (CT) for acute abdominal pain (AAP) in the emergency department; the secondary aim was to compare the diagnostic accuracy of ultrasound (US) and CT in the diagnosis of the aetiology of AAP for diseases that can be diagnosed by US; and the third objective was to assess extent to which inappropriate CT examinations for AAP result in ionizing radiation exposure. Material and methods: In this retrospective single-centre study, we included patients aged between 15 and 46 years referred to the emergency department for AAP in 2016 and submitted to abdominal CT scans, collecting a total of 586 patie…

Anesthesiology and Pain Medicineemergency CTdose billreferralacute abdominal painacute abdominal pain dose bill emergency CT referralPolish journal of radiology
researchProduct

Quantitative Cerebral Blood Flow Mapping in Stroke and During Mental Stimulation After Intravenous Injection of 195mAu

1985

The new short life isotope 195mAu has some suitable features for quantitative cerebral blood flow mapping. Its half-life is 30.5 s; therefore an injection can be repeated after 3 min (six half-lives) without any need for background subtraction and with the same specific activity. The calculated whole body radiation dose after three successive administrations of 25 mCi 195mAu amounts to 50 mrad. In comparison to a 99mTc pertechnetate injection it is estimated that the dose to the patients is reduced by a factor of eight (Garcia et al. 1981).

Background subtractionbusiness.industryRadiation doseStimulation99mtc pertechnetatemedicine.diseaseShort lifeCerebral blood flowAnesthesiamedicineWhole bodyNuclear medicinebusinessStroke
researchProduct

A comparative biochemical, pharmacological and immunological study of Clostridium novyi alpha-toxin, C. difficile toxin B and C. sordellii lethal tox…

1991

The three clostridial cytotoxins, i.e. alpha-toxin of C. novyi (Tox alpha-nov), toxin B of C. difficile (ToxB-dif) and lethal toxin of C. sordellii (LT-sor) consist of single peptide chains of about 200,000 (Tox alpha-nov), 250,000 (LT-sor) and 275,000 (ToxB-dif) mol. wts. ToxB-dif and LT-sor but not Tox alpha-nov cross-reacted with rabbit polyclonal antibodies. Toxicity upon i.v. injection in mice was similar (LD50, 100 hr, 50-200 ng/kg) and was characterized by a slowly developing fluid loss into the interstitial space. When injected into the rat paw the toxins caused a delayed local edema lasting for days. In vitro the three toxins provoked a persistent retraction of endothelial cells cu…

Bacterial ToxinsClostridium sordelliiClostridium difficile toxin BChick EmbryoBiologyPulmonary ArteryToxicologymedicine.disease_causeMedian lethal doseMicrobiologyLethal Dose 50chemistry.chemical_compoundMiceBacterial ProteinsmedicineAnimalsMicroscopy Phase-ContrastUridineCells CulturedClostridiumAdenosine Diphosphate RiboseToxinClostridioides difficileCytotoxinsRats Inbred Strainsbiology.organism_classificationClostridium novyiUridineRatsEndothelial stem cellchemistryADP-ribosylationPotassiumFemaleEndothelium VascularToxicon : official journal of the International Society on Toxinology
researchProduct

Presence of a capsule in Vibrio vulnificus biotype 2 and its relationship to virulence for eels

1993

Strains of Vibrio vulnificus biotype 2, isolated from internal organs of diseased European eels as pure cultures of opaque cells, together with some reference strains from Japanese eels, were used in this study. Spontaneous translucent-phase variants were obtained from the corresponding parent strains and compared for a variety of phenotypic traits related to virulence for eels. The rate of colony dissociation from opaque to translucent cells was higher (around 10(-2)) than that observed for translucent to opaque cells (10(-3) to 10(-4)). Electron microscopy with ruthenium red revealed the presence of a capsule of variable thickness on opaque cells, whereas translucent-type colonies had no …

Bacterial capsuleIronImmunologyVirulenceVibrio vulnificusMicrobiologyHemolysisMicrobiologyFish DiseasesVibrionaceaeAnimalsBacterial CapsulesVibrioEelsbiologyLethal doseTransferrinbiology.organism_classificationVibrioMicroscopy ElectronInfectious DiseasesVibrio InfectionsParasitologyBacterial outer membraneBacteriaBacterial Outer Membrane ProteinsPlasmidsResearch Article
researchProduct

Interaction of Bacillus thuringiensis Cry1 and Vip3A Proteins with Spodoptera frugiperda Midgut Binding Sites

2009

ABSTRACT Vip3Aa, Vip3Af, Cry1Ab, and Cry1Fa were tested for their toxicities and binding interactions. Vip3A proteins were more toxic than Cry1 proteins. Binding assays showed independent specific binding sites for Cry1 and Vip3A proteins. Cry1Ab and Cry1Fa competed for the same binding sites, whereas Vip3Aa competed for those of Vip3Af.

Bioquímicaanimal structuresBiotecnologia agrícolaBacillus thuringiensisPlasma protein bindingSpodopteraSpodopteraHemolysin ProteinsApplied Microbiology and BiotechnologyProtein–protein interactionMicrobiologyLethal Dose 50Hemolysin ProteinsBacterial ProteinsBacillus thuringiensisPlaguicidesInvertebrate MicrobiologyAnimalsBinding siteBacillus thuringiensis ToxinsEcologybiologyfungifood and beveragesMidgutbiology.organism_classificationBacillalesEndotoxinsGastrointestinal TractBiochemistryLarvasense organsProteïnesProtein BindingFood ScienceBiotechnologyApplied and Environmental Microbiology
researchProduct

Role of iron, capsule, and toxins in the pathogenicity of Vibrio vulnificus biotype 2 for mice

1994

The virulence mechanisms of Vibrio vulnificus biotype 2 have been studied and compared with those of biotype 1 in mice as the experimental animals. Biotype 2 isolates from European eels were as virulent for mice as biotype 1 strains (50% lethal dose, about 10(5) CFU per mouse); a septicemic infection developed in less than 24 h. These strains had several properties in common with biotype 1 organisms including capsule expression, uptake of various iron sources, and production of exoproteins, whose role in mouse virulence has been demonstrated. We also discuss the implication of biotype 2 strains in human infections.

Blood Bactericidal ActivityIronImmunologyExotoxinsVirulenceVibrio vulnificusIn Vitro Techniquesmedicine.disease_causeMicrobiologyMicrobiologyMiceSpecies SpecificityVibrionaceaeVibrio InfectionsmedicineAnimalsHumansVibrioEelsVirulencebiologyToxinLethal dosebiology.organism_classificationVibrioBacterial Typing TechniquesInfectious DiseasesVibrio InfectionsParasitologyBacteriaResearch ArticleInfection and Immunity
researchProduct

Hypoglycaemic effect of Spergularia purpurea in normal and streptozotocin-induced diabetic rats

2000

Single and repeated oral administration of the water extracts of Spergularia purpurea (SP) at a dose of 10 mg/kg were tested on hypoglycaemic activity in normal and streptozotocin-induced diabetic rats. In normal rats, the water extract of SP decreased significantly the plasma glucose levels 4 h after single oral administration (P0.01), and one week after repeated oral administration (P0.05). A significant decrease of plasma glucose levels was observed 6 h after a single oral administration of the water extract of S. purpurea in severe hyperglycaemic rats (n=6) from 22.78+/-0.60 to 11.21+/-0.49 mmol/l (P0.001). On other hand, water extract of S. purpurea normalised plasma glucose levels aft…

Blood GlucoseMalemedicine.medical_specialtyBlood sugarPharmacognosyDiabetes Mellitus Experimentallaw.inventionLethal Dose 50MicelawOral administrationInternal medicineDiabetes mellitusDrug DiscoverymedicineAnimalsHypoglycemic AgentsInsulinRats WistarPharmacologyPlants MedicinalBehavior AnimalPlant Extractsbusiness.industryBody Weightmedicine.diseaseStreptozotocinRatsMoroccoEndocrinologyPhytochemicalToxicityPhytotherapybusinessmedicine.drugJournal of Ethnopharmacology
researchProduct